Alcon Sues Apotex To Block Vigamox Generic

Law360, Washington (July 23, 2012, 3:59 PM EDT) -- Alcon Pharmaceuticals Ltd. sued Apotex Inc. in Delaware federal court Friday, alleging the generic-drug maker's application to market a generic antibacterial eye drop infringes on two patents covering Alcon's blockbuster Vigamox.

Apotex informed Alcon on June 7 that it had filed an abbreviated new drug application with the U.S. Food and Drug Administration to produce and market a generic opthalmic drug containing moxifloxacin hydrochloride, which is primarily used to treat conjunctivitis, or “pink eye.”

Alcon is asking that the approval of Apotex's generic competition be withheld...
To view the full article, register now.